US Patent Issued to Helios Shield on Nov. 4 for "Ultra-violet a (UVA) and ultra-violet C (UVC) system and methods for inactivation, reduction and inhibition of growth of coronavirus" (Canadian Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,715, issued on Nov. 4, was assigned to Helios Shield Ltd. (London).

"Ultra-violet a (UVA) and ultra-violet C (UVC) system and methods for inactivation, reduction and inhibition of growth of coronavirus" was invented by Andrew Clark Baird Aubert (Waterdown, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A UVA/UVC system for reducing active levels, on a surface, and inhibiting further growth of coronavirus on the surface, wherein the system has no deleterious effects on a human, in particular on a human eye or epidermis and dermis, wherein the system includes: iv) at least one UVA light source; v) at least one UVC light source; and at least one ...